UiPath Inc.PATH

Buy more

Buy more on a dip to our buy price, which is under today's $13.

5 good· Revenue growth
5 to watch· Funds trimming

$13.06−0.08 (−0.61%)

Price at 3:03 PM ET

After hours · opens in 17h 24m

NYSE · Technology · Software - Infrastructure · Mid-size company

Remind me 3 days before earnings

The price we'd buy PATH at comes with a free account

It also has the whole brief, the scorecard and how the call has moved.A free account gets it on three stocks you pick, plus three long research reports a month.

What would change it

Sources

Analysts' forecast on the Nasdaq earnings calendar
From the 10-Q for the quarter to Jul 31, reported Sep 3
Yahoo Finance daily closes to Nov 11

Any one could move it to Keep

Next report · Dec 3

below$0.10
earnings per share
below7%
sales growth

Compared with the S&P 500

14 points
worse in one day
31 points
worse in five trading days

−9.1% in a yearsince Nov 11, 2025

Earnings report

The news behind our call

written Sep 22, 10:09 AM ETSep 22, 10:09 AM ET · 4 articles · 2 sources

UiPath grew fiscal-second-quarter revenue 13%.
Technology is attracting market leadership while UiPath’s quantitative ranking remains strong.

What changed

From Yahoo Finance, UiPath Inc. via Nasdaq, ServiceNow, Inc. via Yahoo Finance and 1 more

UiPath joined Google Cloud's Gemini for Healthcare as launch partner on Nov 10.

Dec 3

in 21 days

PATH reports earnings after the market closes

Analysts expect $0.10 a share.

Should Gemini Healthcare Tie up Require Action from UiPath (PATH) investors?
Yesterday
UiPath (PATH) could be 40% undervalued following Gemini for Healthcare launch
Yesterday
UiPath (PATH) stock looks Cheap Based on future cash Flow
Yesterday
UiPath (PATH) Declines more than market: Some Information for investors
Tuesday
UiPath joins Google Cloud's Gemini for Healthcare as launch partner — Enables AI-Powered Workflow Automation
Tuesday
UiPath Accelerates Enterprise AI transformation with Google Cloud’s Gemini for Healthcare
Tuesday
UiPath Named a Leader in Everest Group's 2026 agentic Process Automation platform and Full Suite APAP PEAK Matrix® assessments
Nov 5
UiPath announces Third quarter Fiscal 2027 Financial results Conference call
Nov 5

Overview

In plain numbers

Revenue grew 15% from a year earlier, to $1.7B in the last twelve months.
It keeps 9 cents of every revenue dollar as operating profit, up from a loss of 56 cents in FY 2022.
It turned 21% of revenue into free cash flow: $363.0M in the last twelve months.
It holds $1.4B in cash and investments against $79.8M of debt, which leaves $1.3B of net cash.

Key figures

Revenue (TTM): $1.7B
Revenue growth, 1 year: +15.0%
Net income: $362M
EPS (diluted): $0.68
Gross margin: 82.6%
Operating margin: 9.4%

Return on equity: 20.0%
Return on capital: 5.3%
Debt / equity: 0.04
Current ratio: 2.39
Buyback yield: 1.85%

Key facts

Company value: $6.8B
Price / last year's earnings: 19.5×
Today's range: 12.7213.26
Past year's range: 9.3819.29

Yesterday's close: $13.14
Swings vs the market: 1.0×about the same
Next earnings: Dec 3in 21 days

Compare PATH with

PATHvsSQBlock, Inc.